Trial
NCT00863057
Combination Pain Therapy in HIV Neuropathy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
HIV Infections
Intervention
Duloxetine
Why stopped
Due to slow rate of enrollment, which compromised the ability to meet study objectives in a timely manner.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-04